SCI期刊

干细胞转化医学杂志

所属分类:SCI期刊

Stem Cells Translational Medicine期刊基本信息

Stem Cells Translational Medicine
期刊简称

STEM CELL TRANSL MED

期刊ISSN

2157-6564

影响因子

5.962

是否SCI

SCIE

是否开源

No

出版地

UNITED STATES

审稿周期

12 issues/year

创刊年份

2012

研究方向

医学

Stem Cells Translational Medicine中文介绍

《Stem Cells Translational Medicine》是一本由WILEY出版商出版的专业医学期刊,该刊创刊于2012年,刊期12 issues/year,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:细胞与组织工程 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖细胞与组织工程等领域,旨在及时、准确、全面地报道国内外细胞与组织工程工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为7.655,平均审稿速度较慢,6-12周。

Stem Cells Translational Medicine英文介绍

STEM CELLS Translational Medicine is a monthly, peer-reviewed, largely online, open access journal.

STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy. By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes.

The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells, including their characterization and manipulation, and the translation of their clinical aspects of from the bench to patient care. STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.

Stem Cells Translational Medicine中科院分区

大类学科 分区 小类学科 分区 Top期刊 综述期刊
医学 2区 CELL & TISSUE ENGINEERING 细胞与组织工程 2区

Stem Cells Translational Medicine期刊近9年JCR分区变化趋势

Stem Cells Translational MedicineJCR分区(JCR2021-2022年分区)

JCR分区等级 JCR所属学科 分区 影响因子
Q1 CELL & TISSUE ENGINEERING Q1 7.655

Stem Cells Translational Medicine期刊近7年影响因子变化趋势

Stem Cells Translational Medicine期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore SJR SNIP 学科类别 分区 排名 百分位
11.40 1.412 1.511 大类:Medicine 小类:General Medicine Q1 31 / 826

96%

Stem Cells Translational Medicine期刊近7年自引率变化趋势